North America Infusion Devices Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Infusion Pumps and Infusion Sets), Application (Diabetes, Oncology, Pain Management, Hematology, Pediatrics, Gastroenterology, and Others), End User (Hospitals and Specialty Clinics, Homecare Settings, Ambulatory Surgical Centers, and Others), and Country

The North America infusion devices market size is projected to reach US$ 9,116.47 million by 2031 from US$ 5,494.15 million in 2023. The market is expected to register a CAGR of 6.5% during 2023–2031. Owing to the increasing prevalence of cancer and the rising geriatric populations, infusion devices with intelligent features such as easy integration, remote monitoring, and electronic record-keeping are likely to remain key trends in the market in the coming years.

North America Infusion Devices Market Analysis

The global infusion devices market is expected to grow due to the aging population and the growing prevalence of chronic diseases. People over the age of 65 may require infusion pumps for a variety of reasons, including nutrition, hormonal interventions, and medication. Manufacturers are producing more precise, user-friendly, and dependable pumps than ever before. The ongoing technological advancements in infusion devices, making them more accessible to consumers and healthcare professionals, are likely to fuel the North America infusion devices market growth in the future.

North America Infusion Devices Market Overview

Infusion devices are a common medical equipment used by patients with chronic diseases such as cancer and diabetes in hospitals, homes, and healthcare settings. According to the Diabetes Research Institute, the number of people affected by diabetes in the US was ~37.3 million (i.e., 11.3% of the population) in 2022. Furthermore, the latest Global Burden of Disease report, published in October 2020, shows that the prevalence of chronic and infectious diseases such as respiratory infection, cancer, and diabetes is rising in the US. The Canadian Cancer Society estimates 2 out of every 5 Canadians will be diagnosed with cancer during their lifetime.

North America Infusion Devices Market Drivers and Opportunities

Growing Geriatric Population Favors Market Growth

According to the US Census Bureau, the number of Americans aged 65 and above is expected to rise from 58 million in 2022 to 82 million by 2050, which is a 47% increase. Additionally, the share of the total population for the 65-and-older age group is projected to rise from 17% to 23%. According to Statistics Canada, in 2022, almost ~18.8% of Canadians were aged 65 years. Almost 20% of the Canadian population is aged 65 years and above. Furthermore, population projections suggest that 21% to 29% of Canadians could be aged 65 or above by 2068.

A few key benefits of infusion therapy administered in senior populations are listed below.

• Rehydration and electrolyte balance: Dehydration can be a higher risk for seniors due to factors such as decreased thirst, certain medications, and changes in kidney function. IV fluids can help seniors maintain the necessary hydration and electrolyte levels for overall health.

• Nutrition support and improvement: Aging makes it harder for human bodies to consume the right nutrients, increasing the risk of chronic illnesses. Infusion therapy provides a direct way for seniors to get essential minerals, vitamins, and amino acids efficiently.

• Immune function reinforcement: Immune systems of elderly people may need extra support, as they are more vulnerable to infections. Infusion therapy can deliver immune-boosting nutrients such as vitamin C, zinc, and glutathione directly to the body.

• Pain management: Many seniors deal with chronic pain daily, affecting their quality of life. Infusion therapy can quickly and effectively manage pain by delivering medication directly into the bloodstream, providing relief and reducing inflammation.

Thus, the increasing geriatric population drives the demand for infusion devices across North America.

Strategic Initiatives by Market Players to Create Opportunities in Market

Various market players focus on strategic developments such as product launches, mergers, acquisitions, and collaborations to develop advanced products that help ease the treatment of chronic disorders such as diabetes, cancer, and chronic pain. The following are a few recent developments in the North America infusion devices market.

• In April 2024, Mackenzie Health launched a technology in Canada that allows for two-way information flow between an intravenous (IV) medication pump and a patient’s electronic medical record. The technology, known as BD Alaris EMR Interoperability, eliminates the need for healthcare professionals to manually program pumps. It sends infusion safety information back to Epic EMR, reducing the risk of administration errors and providing an accurate infusion record in the EMR.

• In November 2022, Medtronic plc announced the launch of Medtronic Extended infusion set in the US. It is the first and only infusion set labeled for up to seven-day wear. An infusion set is tubing that delivers insulin from an insulin pump to the body and usually needs to be changed every 2–3 days.

• In May 2022, Fresenius Kabi acquired Ivenix, along with its advanced infusion pump technology, expanding its portfolio of advanced infusion pumps and solutions for healthcare professionals to address healthcare needs across the care continuum. This acquisition allowed Fresenius Kabi to rapidly expand its infusion therapy portfolio in the US, obtaining FDA approvals for multiple IV solutions in anticipation of qualifying its North Carolina manufacturing site to supply US customers with IV solutions.

• In March 2022, Fresenius Kabi received 510(k) regulatory clearance from the FDA for its wireless Agilia Connect Infusion System. The system includes the Agilia Volumetric Pump and the Agilia Syringe Pump with Vigilant Software Suite-Vigilant Master Med technology. Both pumps are the first to be cleared following TIR101 standards, which were developed by the Association for the Advancement of Medical Instrumentation in 2021.

An upsurge in the number of product approvals, launches, and strategic collaborations is likely to create lucrative opportunities for the infusion devices market in the future.

North America Infusion Devices Market Report Segmentation Analysis

The key segment that contributed to the derivation of the North America infusion devices market analysis is product type, application, and end user.

• Based on product type, the North America infusion devices market is bifurcated into infusion pumps and infusion sets. The infusion pumps segment held a larger market share in 2023, and it is expected to register a higher CAGR in the market during 2023–2031.
• By application, the market is segmented into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and others. The diabetes segment held the largest share of the market in 2023, and it is projected to register the highest CAGR in the market during 2023–2031.
• Based on end user, the North America infusion devices market is divided into hospitals and specialty clinics, homecare settings, ambulatory surgical centers, and others. The hospitals and specialty clinics segment dominated the market in 2023. The homecare settings segment is anticipated to register the highest CAGR during 2023–2031.

North America Infusion Devices Market Report Scope

North America Infusion Devices Market News and Recent Developments

The North America infusion devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the North America infusion devices market are listed below:

• Moog Inc. received US FDA 510(k) clearance for CURLIN 8000 Ambulatory Infusion System. This premium infusion platform was developed specifically for use in home infusion settings. The CURLIN 8000 combines a reliable and robust design with a simple, intuitive user interface designed for easy navigation by both clinical and nonclinical users. The CURLIN 8000 also integrates seamlessly with CURLIN RxManager, a completely new medication safety software developed to complement existing home infusion workflows. (Source: Moog Inc., Press Release, May 2024)
• Eitan Medical launched its new cutting-edge, connected infusion multi-therapy ambulatory infusion system—Avoset. The connected Avoset Infusion System is designed to transform post-acute care and specialty infusion therapy with compact and simplified technology that can monitor infusion treatment data remotely, subsequently improving patient safety and user experience. (Source: Eitan Medical, Press Release, April 2023)
• ICU Medical Inc. completed the acquisition of Smiths Medical from Smiths Group plc. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products. Combined with ICU Medical’s existing businesses, the company has created a leading infusion therapy business. The acquisition allows ICU Medical to build on a corporate culture that creates value through accountability, thereby operating transparently, making quick and informed decisions, and staying focused on meeting customer needs. (Source: ICU Medical Inc., Press Release, January 2022)

North America Infusion Devices Market Report Coverage and Deliverables

The “North America Infusion Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• North America infusion devices market size and forecast at regional and country levels for all the key market segments covered under the scope
• North America infusion devices market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST and SWOT analysis
• North America infusion devices market analysis covering key market trends, regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the North America infusion devices market
• Detailed company profiles

The List of Companies - North America Infusion Devices Market

• Becton Dickinson and Co
• Fresenius Kabi AG
• B Braun SE
• CODAN US Corp
• Baxter International Inc.
• Elimedical Inc.
• ICU Medical Inc.
• BPL Medical Technologies Pvt Ltd
• Nipro Corp.
• KD Scientific Inc.

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America infusion devices market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the North America infusion devices market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.